Trastuzumab deruxtecan-related risk of ILD and pneumonitis

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2024年 / 2008卷 / 1期
关键词：
D O I：
10.1007/s40278-024-58906-x
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：12 / 12
相关论文
共 50 条
  • [31] Trastuzumab deruxtecan beats trastuzumab emtansine in lowered disease progression, death
    不详
    CANCER, 2022, 128 (15) : 2852 - 2852
  • [32] Managing the Risk of Lung Toxicity with Trastuzumab Deruxtecan (T-DXd): A Canadian Perspective
    Henning, Jan-Willem
    Brezden-Masley, Christine
    Gelmon, Karen
    Chia, Stephen
    Shapera, Shane
    Mcinnis, Micheal
    Rayson, Daniel
    Asselah, Jamil
    CURRENT ONCOLOGY, 2023, 30 (09) : 8019 - 8038
  • [33] The potential of trastuzumab deruxtecan as a tissue agnostic drug
    Jorgensen, Jan Trost
    ONCOLOGY, 2023, 101 (12) : 836 - 842
  • [34] Empower the Potential of Trastuzumab Deruxtecan with Novel Combinations
    Rolfo, Christian
    Del Re, Marzia
    Russo, Alessandro
    CLINICAL CANCER RESEARCH, 2023, 29 (21) : 4317 - 4319
  • [35] SABCS 2020: New Data on Trastuzumab Deruxtecan
    不详
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 (1-2) : 68 - 68
  • [36] Osimertinib/Trastuzumab-deruxtecan/Trastuzumab-emtansineVarious toxicities and lack of efficacy
    Reactions Weekly, 2024, 2006 (1) : 557 - 557
  • [37] Mortality risk prediction with ILD-GAP index in a fibrotic hypersensitivity pneumonitis cohort
    Almeida, Leonor Mendonca
    Fernandes, Ana Luisa
    Cardoso, Catarina Gouveia
    Lima, Bruno
    Neves, Ines
    Novais-Bastos, Helder
    Mota, Patricia Caetano
    Melo, Natalia
    Moura, Conceicao Souto
    Guimaraes, Susana
    Carvalho, Andre
    Cunha, Rui
    Pereira, Jose Miguel
    Morais, Antonio
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2022, 16
  • [38] Mortality risk prediction with ILD-GAP index in a fibrotic hypersensitivity pneumonitis cohort
    Almeida, Leonor Mendonca
    Fernandes, Ana Luisa
    Cardoso, Catarina Gouveia
    Lima, Bruno
    Neves, Ines
    Novais-Bastos, Helder
    Mota, Patricia Caetano
    Melo, Natalia
    Moura, Conceicao Souto
    Guimaraes, Susana
    Carvalho, Andre
    Cunha, Rui
    Pereira, Jose Miguel
    Morais, Antonio
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2022, 16
  • [39] Trastuzumab-Induced Pneumonitis
    Bashir, H. I.
    Tondapu, V.
    Cucci, A. R.
    Venkateshaiah, L. K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [40] Analysis of study drug-related interstitial lung disease (ILD) in patients (pts) with HER2+metastatic breast cancer (mBC) treated with trastuzumab deruxtecan (T-DXd)
    Powell, C. A.
    Modi, S.
    Iwata, H.
    Takahashi, S.
    Nie, K.
    Qin, A.
    Singh, J.
    Taitt, C.
    Verma, S.
    Camidge, D. R.
    ANNALS OF ONCOLOGY, 2021, 32 : S61 - S62
12345